Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy Post author:Sam Post published:February 7, 2018 Post category:BioPharma The FDA approved Gilead’s triple combination treatment for HIV, Biktarvy. Source: BioSpace You Might Also Like Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's July 11, 2017 The IDO Battle Gets Ugly October 24, 2017 Roivant Licenses Diabetes Drug From Ligand Pharma March 6, 2018
Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's July 11, 2017
